Shaping the Future of
Healthcare.
Bridging the gap between academic research, industry practice, and global health policy.
Mission.
To bridge the critical gap between academic research and clinical practice by fostering rigorous, data-driven thinking and championing uncompromised patient-centeredness in modern healthcare policy.
Vision.
To establish our institute as the premier global leader in translating health economics and outcomes research into sustainable, equitable, and actionable healthcare solutions worldwide.
What We Do.
HEOR
Health Economics and Outcomes Research to drive value-based decisions.
Market Access
Navigating global regulatory landscapes and reimbursement strategies.
Public Health
Advancing community wellness through evidence-based interventions.
AI & Digital Health
Integrating machine learning and digital tools into modern care.
Research & Policy
Translating complex data into actionable government and clinical policy.
Our scope is dynamic, constantly extending to emerging healthcare and research domains.
"Policy without evidence is guesswork. Evidence without policy is just data."
When we established the Institute of Health Economics and Policy Research, we recognized a fundamental disconnect. Brilliant clinical research was being published daily, yet it took years—sometimes decades—for those insights to shape the policies that actually save lives.
Our mandate is simple but ambitious: to collapse the timeline between discovery and implementation. By bridging the worlds of academic rigor and governmental strategy across India, Singapore, and the UK, we are creating a new blueprint for market access and global health equity.
Dr. Ajit Singh
Founder & Executive Director
"True innovation in healthcare is measured by its accessibility, not just its ingenuity."
The future of healthcare doesn't just rely on creating better treatments; it relies on building better systems to deliver them. We must look beyond the laboratory and into the economic realities of diverse populations.
By cultivating a new generation of leaders trained in HEOR and Market Access, we ensure that groundbreaking digital health technologies and therapeutics don't just exist in a vacuum, but reach the patients who need them most efficiently and equitably.
Dr. Richa Goyal
Co-Founder & Director of Research
Global Perspectives.
Guided by an independent panel of world-renowned experts in health economics, regulatory affairs, and clinical research.
Dr. Elena Rostova
Chair of Health Economics
London School of Economics (LSE)
Prof. Marcus Chen
Global Policy Advisor
National University of Singapore (NUS)
Dr. Sarah Jenkins
Digital Health Lead
Imperial College London
Dr. Omar Tariq
Market Access Strategist
Former Director, FDA Regulatory Affairs
Dr. Elena Rostova
Chair of Health Economics
London School of Economics (LSE)
Prof. Marcus Chen
Global Policy Advisor
National University of Singapore (NUS)
Dr. Sarah Jenkins
Digital Health Lead
Imperial College London
Dr. Omar Tariq
Market Access Strategist
Former Director, FDA Regulatory Affairs
Learn From Industry Practitioners.
Dr. Arvind Patel
MD, MPH
Former Director, WHO SEARO
Sarah Jenkins
PharmD, HEOR
Novartis Global
Dr. Marcus Chen
PhD, Health Economics
National University of Singapore
Emily Rostova
MSc, Market Access
GlaxoSmithKline (GSK)
Dr. Omar Tariq
MD, MBA
McKinsey & Company
Priya Sharma
PhD, Public Health
Public Health England
Dr. James Wilson
PharmD, RPh
Pfizer Market Access
Anita Desai
MSc, Health Data Science
Imperial College London
Dr. Thomas Wright
MD, PhD
National Institutes of Health (NIH)
Maria Gonzalez
MPH, Policy Strategy
AstraZeneca
Dr. Kenji Sato
PhD, Biostatistics
Takeda Pharmaceuticals
Rachel Green
MSc, HEOR
NICE (UK)
Dr. Arvind Patel
MD, MPH
Former Director, WHO SEARO
Sarah Jenkins
PharmD, HEOR
Novartis Global
Dr. Marcus Chen
PhD, Health Economics
National University of Singapore
Emily Rostova
MSc, Market Access
GlaxoSmithKline (GSK)
Dr. Omar Tariq
MD, MBA
McKinsey & Company
Priya Sharma
PhD, Public Health
Public Health England
Dr. James Wilson
PharmD, RPh
Pfizer Market Access
Anita Desai
MSc, Health Data Science
Imperial College London
Dr. Thomas Wright
MD, PhD
National Institutes of Health (NIH)
Maria Gonzalez
MPH, Policy Strategy
AstraZeneca
Dr. Kenji Sato
PhD, Biostatistics
Takeda Pharmaceuticals
Rachel Green
MSc, HEOR
NICE (UK)
Our Collaborators.
CliMed
Clinical & Regulatory Research Partner
DUAL SPHERE
Digital Health & Technology Partner
UNIVERSITY
Academic & Certification Partner
INSTITUTE
Strategic Policy Partner